NUVB vs QURE: stock comparison and AI forecast
Nuvation Bio Inc. (NUVB) and Uniqure N.V. (QURE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
NUVB Nuvation Bio Inc.
- Price
- $4.69 -2.9% · 6M
- Market Cap
- $1.65B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
QURE Uniqure N.V.
- Price
- $23.87 +12.8% · 6M
- Market Cap
- $1.66B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- NUVB and QURE have similar market capitalizations ($1.65B and $1.66B).
- Over the last six months QURE returned +12.8% and NUVB -2.9%.
- NUVB turns -88.2% of its revenue into net income, against -1154.4% for QURE.
- QURE carries 4.21 times debt per unit of equity, against 1.93 times for NUVB.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | NUVB | QURE |
|---|---|---|
| Market Cap | $1.65B | $1.66B |
| P/B Ratio | 6.49x | 11.12x |
| EPS | $-0.61 | $-3.49 |
| Book Value/Share | $0.72 | $2.15 |
| Revenue/Share | $0.48 | $0.26 |
| FCF/Share | – | $-2.48 |
Profitability & Margins
| Metric | NUVB | QURE |
|---|---|---|
| ROE | -59.0% | -139.9% |
| ROA | -20.1% | -26.8% |
| ROIC | -20.9% | -26.6% |
| Gross Margin | 92.8% | 90.6% |
| Operating Margin | -81.0% | -1059.7% |
| Net Margin | -88.2% | -1154.4% |
| EBT Margin | -88.2% | -1123.3% |
| Tax Rate | 0.0% | -2.8% |
Financial Health
| Metric | NUVB | QURE |
|---|---|---|
| Current Ratio | 8.37x | 10.40x |
| Quick Ratio | 8.14x | – |
| D/E Ratio | 1.93x | 4.21x |
| Financial Leverage | 2.93x | 5.21x |
| Interest Coverage | -6.8x | -6.8x |
| Working Capital | $640M | $557M |
Cash Flow
| Metric | NUVB | QURE |
|---|---|---|
| Operating Cash Flow | -$121M | -$172M |
| Free Cash Flow | – | -$173M |
| Capital Spending | – | -$450K |
| FCF/Sales | – | -953.7% |
| CapEx/Sales | – | 2.5% |
Operational Efficiency
| Metric | NUVB | QURE |
|---|---|---|
| Asset Turnover | 0.23x | 0.02x |
| Receivables Turnover | 6.1x | 5.1x |
| Inventory Turnover | 0.6x | – |
| Fixed Assets Turnover | 237.6x | 1.5x |
| Days Sales Outstanding | 60 days | 72 days |
| Days Inventory | 594 days | – |
| Payables Period | 361 days | 940 days |
| Cash Conversion Cycle | 293 days | – |
Income Statement
| Metric | NUVB | QURE |
|---|---|---|
| Total Revenue | $170M | $18M |
| Operating Income | -$138M | -$192M |
| Net Income | -$150M | -$209M |
| R&D Expense | $129M | $134M |
| SG&A Expense | $159M | $75M |
| Cost of Goods Sold | $12M | $2M |
Dividend & Shareholder Information
| Metric | NUVB | QURE |
|---|---|---|
| Shares Outstanding | 351M | 70M |
NUVB vs QURE: stock comparison and AI forecast
Which is bigger, NUVB or QURE?
NUVB and QURE have similar market capitalizations ($1.65B and $1.66B).
Which stock performed better over the last six months, NUVB or QURE?
Over the last six months QURE returned +12.8% and NUVB -2.9%.
Which one does Intratio's AI model rank higher, NUVB or QURE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.